Here are Wednesday’s biggest analyst calls: Nvidia, Apple, Netflix, Meta, Tesla, Eli Lilly, Walmart, Microsoft, Oracle & more
Here are the biggest calls on Wall Street on Source link
Read More
Eli Lilly and Co
Companies besides tech can reach megacap status, Jim Cramer says
CNBC's Jim Cramer discusses how pharmaceutical giant Eli Lilly is successful, similar to Big Tech, through innovation. Source link
Read More
Stocks making the biggest moves premarket: Paramount, SolarEdge, Morphic Holding and more
These are the stocks posting the largest moves in premarket trading. Source link
Read More
This ETF is trying to satisfy appetites for weight loss stocks
Tema ETFs is behind the GLP-1, Obesity & Cardiometabolic ETF (HRTS), which is up 26% since its inception last November.
Read More
Investors want proof AI will aid drug discovery. Evidence may come in the second half
Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read More
Stocks making the biggest moves premarket: Paramount, Tesla, Constellation Brands and more
These are the stocks posting the largest moves in premarket trading. Source link
Read More
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
It's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an
Read More
Pharma ETF that’s gone nowhere for 9 years forming ‘monstrous bullish pattern,’ according to the charts
Frank Cappelleri breaks down the trade on the iShares U.S. Pharmaceuticals ETF. Source link
Read More
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Drugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant
Read More